ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APLHarry Iland, Andrew H. Wei, Liane Khoo et al.|Blood Advances|2025Cited by 4
PS1028 ALLG APML5: A COMPARATIVE BIOAVAILABILITY STUDY OF ENCAPSULATED ORAL ARSENIC TRIOXIDE AND INTRAVENOUS ARSENIC TRIOXIDE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA UNDERGOING CONSOLIDATION THERAPYHarry Iland, C. Risteski, John Reynolds et al.|HemaSphere|2019Cited by 1